Drug intelligence / Profile preview

FORRAD (Forrad Pharmaceutical)

Development stage
Unknown
Lead developer
Yun-fei Xia
Modality
Hydrogel Systems → Drug Delivery Systems
Administration
Topical
01

Overview

FORRAD (also known as Oral Ulcer Gargle) is a proprietary mucoadhesive hydrogel formulation developed for the management of radiation-induced oral mucositis (stomatitis). It is primarily indicated for patients with nasopharyngeal carcinoma undergoing intensity-modulated radiation therapy (IMRT). The formulation works by creating a viscous, protective barrier over the oral mucosa, which shields the tissue from further injury and provides a palliative effect to facilitate healing. In clinical studies led by Yun-fei Xia at Sun Yat-sen University Cancer Center, FORRAD has been evaluated in Phase 2 trials to compare its efficacy and safety against a standard quadruple mixture of dexamethasone, gentamicin, vitamin B12, and procaine.

Brand names
FORRAD
Other names
Oral Ulcer GargleO-Yun-fei Xia-stomatitis (radiation-induced)

Beyond the preview

Go deeper on FORRAD (Forrad Pharmaceutical).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on FORRAD (Forrad Pharmaceutical).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call